Report: Approving 7 Complex Generics Would Save US $1.3B Annually

By John Wilkerson / February 9, 2021 at 5:38 PM
The United States would save $1.3 billion annually if FDA were to approve seven complex generics already available in Canada or Europe, according to report by US Matrix Global Advisors. Congress must renew FDA’s generic user fee program next year, and that is viewed as the vehicle for speeding complex generic drug approvals. Complex generics copy brand drugs with complex molecular bases, routes of delivery, formulations or dosage forms They can be drug-device combination product, such as generic versions of...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.